Pete, I think it likely that will not happen because there would be very little that Dr Mathers could safely say in a professional forum before results are announced to the whole market.
We know that results are not due until FY24 Q3 so I suppose the PAA sponsorship and purpose is to network and raise awareness that those results are coming and to communicate the plans.
That said we could get a Cohort 4 and all patient status report this week to inform everyone, it would be timely considering the conference and AGM. I reckon we’d all like that.
Regards
FDA Application for Orphan Drug Designation , PAA, MPL, page-198
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
22.0¢ |
Change
0.015(7.32%) |
Mkt cap ! $87.1M | |||
| Open | High | Low | Value | Volume |
| 21.0¢ | 22.0¢ | 21.0¢ | $134.7K | 629.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 24563 | 21.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 23.0¢ | 64222 | 3 |
View Market Depth
| Last trade - 16.10pm 07/06/2024 (20 minute delay) ? |
|
|||||
|
Last
21.5¢ |
Change
0.015 ( 2.38 %) |
||||
| Open | High | Low | Volume | ||
| 21.0¢ | 22.0¢ | 21.0¢ | 340156 | ||
| Last updated 15.57pm 07/06/2024 ? | |||||
| PAA (ASX) Chart |